Evidence map›Paper›PMID 35224216›Full record

ReviewHealth science reports2022

Prenatal and neonatal complications of COVID-19: A systematic review.

Zahra Pashaei, SeyedAhmad SeyedAlinaghi, Kowsar Qaderi, Alireza Barzegary, Amirali Karimi, Seyed Peyman Mirghaderi, Pegah Mirzapour, Marcarious M Tantuoyir, Omid Dadras, Zoha Ali and 2 more

RetractedOpen access · goldAbstract readReviewRetracted Publication
In one paragraph

Review in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 5 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 5 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Zahra PashaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran University of Medical Sciences Tehran Iran.
SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran University of Medical Sciences Tehran Iran.
Kowsar QaderiDepartment of Midwifery, School of Nursing and Midwifery Kermanshah University of Medical Sciences Kermanshah Iran.
Alireza BarzegarySchool of Medicine Islamic Azad University Tehran Iran.ORCID https://orcid.org/0000-0002-0512-7014
Amirali KarimiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Seyed Peyman MirghaderiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran University of Medical Sciences Tehran Iran.
Marcarious M TantuoyirIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran University of Medical Sciences Tehran Iran.
Omid DadrasSchool of Public Health Walailak University Nakhon Si Thammarat Thailand.ORCID https://orcid.org/0000-0001-9385-2170
Zoha AliIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran University of Medical Sciences Tehran Iran.
Fabricio VoltarelliGraduation Program of Health Sciences, Faculty of Medicine Federal University of Mato Grosso Cuiabá Brazil.
Esmaeil MehraeenDepartment of Health Information Technology Khalkhal University of Medical Sciences Khalkhal Iran.ORCID https://orcid.org/0000-0003-4108-2973
Iranian Institute for Health Sciences Research · IRTehran University of Medical Sciences · IRIslamic Azad University, Tehran · IRKermanshah University of Medical Sciences · IRLorestan University of Medical Sciences · IRUniversidade Federal de Mato Grosso · BRUniversity of Ghana · GHWalailak University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsThe outbreak of coronavirus disease 2019 (COVID-19) over the past year has affected public health worldwide. During pregnancy, the maternal immune system and inflammatory responses are widely suppressed. Pregnancy-related immune system suppression could make the mother vulnerable to infectious diseases like SARS-COV-2. However, current data suggest little to no possibility of COVID-19 transmission in pregnant women to the fetus during pregnancy or childbirth. This systematic review focused on the possible complications of COVID-19 infection in the fetus and newborn babies including the possibility and evidence of vertical transmission by reviewing articles published during the first year of the COVID-19 pandemic.

methodsWe conducted a systematic search using keywords on PubMed, Embase, and Scopus databases. The studies followed a title/abstract and a full-text screening process, and the eligible articles were included in the study.

resultsIn total, 238 published papers were identified using a systematic search strategy (44 articles met the inclusion criteria and were included in the final review). In all studies, a total of 2375 women with signs and symptoms of COVID-19, who were in the second and third trimester of pregnancy, were assessed mild to moderate pneumonia was one of the most common symptoms. Seventy-three percent of the women did not present any comorbidity, 19% had a fever, 17% had to cough as the most frequent clinical signs and symptoms, 7.5% had pulmonary changes with chest scans, 8% had increased C reactive protein, and 9.4% had decreased lymphocytes (lymphocytopenia). A total of 2716 newborns and fetal were assessed; the delivery method of 1725 of them was reported, 913 (53%) through C-section delivery, and 812 through normal vaginal delivery (47%). Of total newborns, 13 died (five died along with the mother), and 1965 were tested for SARS-CoV-2:118 tested positive. In a study, vertical transmission in seven cases was reported in total of 145 cases assessed.

conclusionIt appeared that most pregnant COVID patients were mildly ill, and there is currently no convincing evidence to support the vertical transmission of COVID-19 disease. Therefore, neonates do not represent any additional risk for adverse outcomes neither during the prenatal period nor after birth.

Indexed as

COVID‐19fetusneonatalnewbornprenatalSARS‐CoV‐2

Identifiers

PMID35224216
PMCPMC8844871
OpenAlexW4212801045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.